Streetbeat News

Stock Prices

COSM

Cosmos Health reaffirms its 2026 financial targets with gross annual revenue over $180M and annual EBITDA above $20M. The company plans to spin off its R&D division into a separate public entity. Despite its achievements and growth prospects, Cosmos Health notes a discrepancy between its stock price and book value, which is threefold the current share price. In Q3 2023, Cosmos Health began a stock buyback program and is looking into further measures to support its shareholders.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:06 pm

COSM

Cosmos Health (NASDAQ:COSM) reported a 6.72% increase in Q3 sales to $12.82M from $12.02M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:03 pm

OXM

Over the past 3 months, 3 analysts have provided 12-month price targets for Oxford Industries (NYSE:OXM), with an average target of $114.00, a high of $120.00, and a low of $107.00. This average is a 6.94% decrease from the previous target of $122.50. The ratings include 1 somewhat bullish and 2 indifferent, with no fully bullish or bearish ratings.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 2:00 pm

NOVA

Sunnova Energy Intl (NYSE:NOVA) has received various analyst ratings over the last quarter, with 6 bullish, 8 somewhat bullish, and 5 indifferent ratings. The average 12-month price target from 19 analysts is $21.18, which is a 26.43% decrease from the previous target of $28.79. The high target is $58.00 and the low is $11.00.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 2:00 pm

VTVT

VTv Therapeutics shares have resumed trading after a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:00 pm

ROST

Ross Stores (NASDAQ:ROST) has delivered an average annual return of 11.89% over the past 20 years, outperforming the market. A $100 investment in ROST 20 years ago would be worth $945.60 today. The company's current market capitalization stands at $43.85 billion.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 2:00 pm

GDS

GDS Holdings (NASDAQ:GDS) is expected to release its quarterly earnings report on Wednesday, 2023-11-22, with analysts predicting an EPS of $-0.27. Investors are looking for an earnings beat and positive guidance for future growth. GDS Holdings has a history of mixed earnings performance, with the stock price reacting variably to past earnings results. Shares are currently trading at $11.77, with a slight increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 2:00 pm

ENTA

Enanta Pharma (NASDAQ:ENTA) has received 5 analyst ratings in the last quarter, with 3 being bullish, 1 somewhat bullish, and 1 indifferent. The average price target is $28.8, which is significantly higher than the current price of $9.18, suggesting a substantial upside. However, this target has decreased by 20.55% from the previous target of $36.25. Analyst ratings are provided by financial specialists and can influence stock performance.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 2:00 pm

ASML

ASML Holding (NASDAQ:ASML) has significantly outperformed the market, with an average annual return of 32.87% over the past 5 years. A $1000 investment in ASML 5 years ago would be worth $4,236.10 today. ASML's market capitalization currently stands at $273.56 billion.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 2:00 pm

COMP

Compass (NYSE:COMP) has received 5 analyst ratings in the last quarter, with 3 being bullish, 2 indifferent, and none bearish. The average 12-month price target among these analysts is $3.09, with a high of $4.00 and a low of $2.25. This target suggests a 29.45% decrease from the previous target of $4.38. Analyst ratings are periodic evaluations of stocks by financial experts based on research and company performance.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 2:00 pm